KF is a point-of-care medical devices manufacturer
They are a global medical manufacturer of point-of-care (POCT) devices and tests including hemoglobin tests, HbA1c tests, glucose and lactate tests.
EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries.
EKF specialises in developing tests for use in diabetes and anemia diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.
EKF Diagnostics Holdings plc is listed on the London Stock Exchange. The ordinary shares are traded on the AIM market. For Investor Announcements, Company information and background to the Board of Directors and Advisors view the Investors section of this website.See more